Back to today’s briefing

Story perspectives

Cancer Gene Therapy Market to Surge to $10 Billion

3/27/2025

35 8

Summary

Story summary

The Global Cancer Gene Therapy Market is set to soar from $2.5 billion in 2024 to an impressive $10 billion by 2032, fueled by an 18% annual growth rate. Major players like Amgen and Novartis are at the forefront, navigating hurdles such as steep research costs. North America dominates, while Asia-Pacific emerges as the fastest-growing region, promising hope in the fight against cancer.

1 of 1

Story summary

The Global Cancer Gene Therapy Market is set to soar from $2.5 billion in 2024 to an impressive $10 billion by 2032, fueled by an 18% annual growth rate. Major players like Amgen and Novartis are at the forefront, navigating hurdles such as steep research costs. North America dominates, while Asia-Pacific emerges as the fastest-growing region, promising hope in the fight against cancer.